Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report

Standard

Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report. / Heesen, Christoph; Bruce, Jared; Feys, Peter; Sastre-Garriga, Jaume; Solari, Alessandra; Eliasson, Lina; Matthews, Vicki; Hausmann, Bettina; Ross, Amy Perrin; Asano, Miho; Imonen-Charalambous, Kaisa; Köpke, Sascha; Clyne, Wendy; Bissell, Paul.

In: MULT SCLER J, Vol. 20, No. 13, 01.11.2014, p. 1795-8.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Heesen, C, Bruce, J, Feys, P, Sastre-Garriga, J, Solari, A, Eliasson, L, Matthews, V, Hausmann, B, Ross, AP, Asano, M, Imonen-Charalambous, K, Köpke, S, Clyne, W & Bissell, P 2014, 'Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report', MULT SCLER J, vol. 20, no. 13, pp. 1795-8. https://doi.org/10.1177/1352458514531348

APA

Heesen, C., Bruce, J., Feys, P., Sastre-Garriga, J., Solari, A., Eliasson, L., Matthews, V., Hausmann, B., Ross, A. P., Asano, M., Imonen-Charalambous, K., Köpke, S., Clyne, W., & Bissell, P. (2014). Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report. MULT SCLER J, 20(13), 1795-8. https://doi.org/10.1177/1352458514531348

Vancouver

Bibtex

@article{dad4224ed16f43de853ca763c8bde65c,
title = "Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report",
abstract = "BACKGROUND: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied.METHODS: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session.RESULTS: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions.CONCLUSIONS: A focus on patient preferences as well as a non-judgmental discussion on adherence issues with patients should be at the core of adherence work.",
author = "Christoph Heesen and Jared Bruce and Peter Feys and Jaume Sastre-Garriga and Alessandra Solari and Lina Eliasson and Vicki Matthews and Bettina Hausmann and Ross, {Amy Perrin} and Miho Asano and Kaisa Imonen-Charalambous and Sascha K{\"o}pke and Wendy Clyne and Paul Bissell",
note = "{\textcopyright} The Author(s), 2014.",
year = "2014",
month = nov,
day = "1",
doi = "10.1177/1352458514531348",
language = "English",
volume = "20",
pages = "1795--8",
journal = "MULT SCLER J",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "13",

}

RIS

TY - JOUR

T1 - Adherence in multiple sclerosis (ADAMS): classification, relevance, and research needs. A meeting report

AU - Heesen, Christoph

AU - Bruce, Jared

AU - Feys, Peter

AU - Sastre-Garriga, Jaume

AU - Solari, Alessandra

AU - Eliasson, Lina

AU - Matthews, Vicki

AU - Hausmann, Bettina

AU - Ross, Amy Perrin

AU - Asano, Miho

AU - Imonen-Charalambous, Kaisa

AU - Köpke, Sascha

AU - Clyne, Wendy

AU - Bissell, Paul

N1 - © The Author(s), 2014.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - BACKGROUND: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied.METHODS: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session.RESULTS: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions.CONCLUSIONS: A focus on patient preferences as well as a non-judgmental discussion on adherence issues with patients should be at the core of adherence work.

AB - BACKGROUND: Adherence to medical interventions is a global problem. With an increasing amount of partially effective but expensive drug treatments adherence is increasingly relevant in multiple sclerosis (MS). Perceived lack of efficacy and side effects as well as neuropsychiatric factors such as forgetfulness, fatigue and depression are major determinants. However, research on adherence to behavioural interventions as part of rehabilitative interventions has only rarely been studied.METHODS: In a one-day meeting health researchers as well as patient representatives and other stakeholders discussed adherence issues in MS and developed a general draft research agenda within a focus group session.RESULTS: The focus group addressed four major areas: (1) focussing patients and their informal team; (2) studying health care professionals; (3) comparing practice across cultures; and (4) studying new adherence interventions.CONCLUSIONS: A focus on patient preferences as well as a non-judgmental discussion on adherence issues with patients should be at the core of adherence work.

U2 - 10.1177/1352458514531348

DO - 10.1177/1352458514531348

M3 - SCORING: Journal article

C2 - 24756569

VL - 20

SP - 1795

EP - 1798

JO - MULT SCLER J

JF - MULT SCLER J

SN - 1352-4585

IS - 13

ER -